Today: 3 April 2026
Hongkong Land stock price slips in Singapore as buyback filing lands and Hong Kong housing data turns heads
28 January 2026
1 min read

Hongkong Land stock price slips in Singapore as buyback filing lands and Hong Kong housing data turns heads

SINGAPORE, Jan 28, 2026, 15:17 SGT — Regular session

  • Hongkong Land shares slipped slightly, hovering close to a 52-week high in Singapore trading
  • Company revealed a new share buyback along with intentions to cancel the shares
  • Investors are focusing on property data sensitive to rates as they await the Fed’s decision set for later Wednesday

Hongkong Land Holdings Ltd (SGX: H78) shares slipped 0.2% to $8.40 by 3:08 p.m. Singapore time Wednesday, fluctuating between $8.22 and $8.46 earlier. The stock hovered just under its 52-week peak. SG Investors

The slight drop is still significant. The stock surged late January but now trades in a zone where buyback news, rate chatter, and property updates typically hit faster than normal.

A routine market filing on Tuesday intensified the scrutiny. Hongkong Land announced it bought back 175,000 ordinary shares on Jan. 26 at a weighted average price of $8.2844, with individual purchases ranging from $8.21 to $8.35. The repurchased shares will be cancelled. Investegate

The Hong Kong property scene is showing signs of shifting. Private home prices climbed 3.3% in 2025, marking the first yearly increase since 2021, according to government figures. Still, prices remain nearly 30% shy of their 2021 peak. Major Hong Kong banks cut rates again in October—their fifth cut since September 2024. CBRE’s Eddie Kwok credited last year’s stock-market rally for a “wealth effect” that could boost home prices 3%-5% in 2026. Meanwhile, Morgan Stanley’s Praveen Choudhary predicts a 10% rise this year, citing strong investment demand, steady rents, and an influx of mainland talent and students. Reuters

Hongkong Land develops and invests in property throughout Hong Kong and the surrounding region, focusing on offices, retail, and residential sectors. It trades in U.S. dollars on the Singapore Exchange. StockAnalysis

The buyback prices revealed for Jan. 26 hover near today’s trading levels, offering investors a handy benchmark to track.

Yet a stock hovering close to its yearly peak can quickly become volatile. Should rate forecasts shift unfavorably or the housing recovery lose steam once more, buybacks by themselves might not be enough to hold support.

For now, all eyes turn to macro. The U.S. Federal Reserve meets Wednesday to set rates. No change is anticipated, but the market is zeroed in on clues about the timing of rate cuts this year. Reuters

Stock Market Today

  • Sun Pharma Shares Under Pressure After Trump Imposes Tariffs on Imported Drugs
    April 3, 2026, 4:11 AM EDT. Sun Pharma shares will be closely watched after President Trump issued an executive order imposing 100% tariffs on imported branded pharmaceuticals unless manufacturers cut prices or produce locally. Although generic drugs are exempt and some big pharma firms have negotiated to avoid tariffs, mid-sized companies like Sun Pharma face risks. Jefferies notes Sun Pharma earns about 20% of its revenue from innovative drugs produced mainly in South Korea, the EU, or the U.S.-regions subject to a 15% tariff, capping potential impact. The stock dropped nearly 2% to ₹1,694.65 on April 2 but showed signs of buying interest Friday, suggesting possible short-term recovery towards ₹1,730-₹1,750. Immediate support is at ₹1,640, key for sustaining any rebound.
Jardine Matheson stock price slides 4% as MSCI’s Indonesia warning dents sentiment
Previous Story

Jardine Matheson stock price slides 4% as MSCI’s Indonesia warning dents sentiment

iFAST share price steadies near S$11 after ShopeePay Money+ launch sparks a jump
Next Story

iFAST share price steadies near S$11 after ShopeePay Money+ launch sparks a jump

Go toTop